Host fatty acids enhance dengue virus infectivity
Mosquito-borne flavivirus infections cause changes in host lipid metabolism. For example, scientists found that the dengue virus, which has no known antiviral treatments, recruits host fatty acid synthase to aid in viral replication. In a recent Journal of Biological Chemistry , Julia Hehner at Philipps University Marburg and a team in Germany investigated the reliance of various flaviviruses on host fatty acid elongases and desaturases, key enzymes in the biosynthesis of monounsaturated and polyunsaturated fatty acids.

Working with a human hepatic cell line, the authors used RNA interference to individually knock down each fatty acid elongase and desaturase, enzymes that catalyze specific steps for producing fatty acids of different lengths. They exposed the cell lines to dengue, Zika, West Nile, yellow fever and tick-borne encephalitis viruses to measure viral replication. Only dengue virus showed sensitivity to the knockdowns, indicating that this virus relies on fatty acids of specific lengths, while the other viruses can compensate for the loss of one enzyme. Knocking down either the ultra-long-chain elongase ELOVL4 or desaturase FADS2 caused decreased dengue viral titers.
The researchers determined that ELOVL4 knockdown led to slightly lower viral protein levels in the infected cells, possibly signaling ELOVL4 involvement in delaying RNA replication. Surprisingly, the cells lacking FADS2 showed a slight increase in viral protein levels. The authors next measured plaque formation of dengue virus particles produced by the knockdown cell lines and found that cells lacking FADS2 produced viral particles with diminished infectivity. This indicates that FADS2 may promote lipid synthesis necessary for dengue virion assembly.
Future studies will help address the mechanisms behind the observed increase in viral protein levels upon FADS2 knockdown. Further experiments will also help researchers fill in the mechanistic details about how the ultra-long-chain fatty acids produced by ELOVL4 enhance dengue virus infectivity.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

How sugars shape Marfan syndrome
Research from the University of Georgia shows that Marfan syndrome–associated fibrillin-1 mutations disrupt O glycosylation, revealing unexpected changes that may alter the protein's function in the extracellular matrix.

What’s in a diagnosis?
When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.

Peer through a window to the future of science
Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.

Glow-based assay sheds light on disease-causing mutations
University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.

How signals shape DNA via gene regulation
A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent ɬÀï·¬ paper.

A game changer in cancer kinase target profiling
A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent ɬÀï·¬ paper.